Members of TGF-β family of proteins are considered today as the major inducers of EndMT, both in physiologic cardiac development (Garside et al., 2013) but also in cancer, as TGF-βs are soluble factors often found overexpressed in tumors (Principe et al., 2014). The gene discussed is TGFB1; the disease is cancer.